Literature DB >> 23435593

Left atrial volumetry from routine diagnostic work up prior to pulmonary vein ablation is a good predictor of freedom from atrial fibrillation.

Christian Sohns1, Jan M Sohns, Dirk Vollmann, Lars Lüthje, Leonard Bergau, Marc Dorenkamp, Paul A Zwaka, Gerd Hasenfuß, Joachim Lotz, Markus Zabel.   

Abstract

AIMS: This study aimed to identify whether left atrial (LA) volume assessed by multidetector computed tomography (MDCT) is related to the long-term success of pulmonary vein ablation (PVA). MDCT is used to guide PVA for the treatment of atrial fibrillation (AF). MDCT permits accurate sizing of LA dimensions. METHODS AND
RESULTS: We analysed data from 368 ablation procedures of 279 consecutive patients referred for PVA due to drug-refractory symptomatic AF (age 62 ± 10; 58% men; 71% paroxysmal AF). Prior to the procedure, all patients underwent ECG-gated 64-MDCT scan for assessment of LA and PV anatomy, LA thrombus evaluation, LA volume estimation, and electroanatomical mapping integration. Within a mean follow-up of 356 ± 128 days, 64% of the patients maintained sinus rhythm after the initial ablation, and 84% when including repeat PVA. LA diameter (P = 0.004), LA volume (P = 0.002), and type of AF (P = 0.001) were independent predictors of AF recurrence in univariate analysis. There was a relatively low correlation between the echocardiographic LA diameter and LA volume from MDCT (P = 0.01, r = 0.5). In multivariate analysis, paroxysmal AF (P < 0.006) and LA volume below the median value of 106 mL (P = 0.042) were significantly associated with the success of PVA, whereas LA diameter was not (P = 0.245). Analysing receiver-operator characteristics, the area under the curve for LA volume was 0.73 (P = 0.001) compared with 0.60 (P = 0.09) for LA diameter from echocardiography.
CONCLUSION: LA volume assessed by MDCT is a better predictor of AF recurrence after PVA than echocardiograpic LA diameter and can be derived from the pre-procedural imaging data set.

Entities:  

Keywords:  Atrial fibrillation; Left atrium; Multidetector computed tomography; Pulmonary vein ablation

Mesh:

Year:  2013        PMID: 23435593     DOI: 10.1093/ehjci/jet017

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  19 in total

1.  Remote magnetic navigation for circumferential pulmonary vein ablation: single-catheter technique or additional use of a circular mapping catheter?

Authors:  Dirk Vollmann; Lars Lüthje; Joachim Seegers; Christian Sohns; Samuel Sossalla; Jan Sohns; Christian Röver; Gerd Hasenfuß; Markus Zabel
Journal:  J Interv Card Electrophysiol       Date:  2014-06-04       Impact factor: 1.900

2.  Left atrial volume computed by 3D rotational angiography best predicts atrial fibrillation recurrence after circumferential pulmonary vein isolation.

Authors:  Teresa Strisciuglio; Giuseppe Di Gioia; Sofia Chatzikyriakou; Etel Silva Garcia; Emanuele Barbato; Peter Geelen; Tom De Potter
Journal:  Int J Cardiovasc Imaging       Date:  2017-09-16       Impact factor: 2.357

3.  Right Atrial Volume is Increased in Corrected Tetralogy of Fallot and Correlates with the Incidence of Supraventricular Arrhythmia: A CMR Study.

Authors:  Jan M Sohns; Christina Rosenberg; Antonia Zapf; Christina Unterberg-Buchwald; Wieland Staab; Andreas Schuster; Johannes T Kowallick; Olga Hösch; Thuy-Trang Nguyen; Martin Fasshauer; Thomas Paul; Joachim Lotz; Michael Steinmetz
Journal:  Pediatr Cardiol       Date:  2015-04-11       Impact factor: 1.655

4.  Measurements of the left atrium and pulmonary veins for analysis of reverse structural remodeling following cardiac ablation therapy.

Authors:  Maryam E Rettmann; David R Holmes; Jerome F Breen; Xin Ge; Ronald A Karwoski; Kristi H Monahan; Tristram D Bahnson; Douglas L Packer; Richard A Robb
Journal:  Comput Methods Programs Biomed       Date:  2014-11-13       Impact factor: 5.428

5.  Comparison of left atrial dimensions in CT and echocardiography as predictors of long-term success after catheter ablation of atrial fibrillation.

Authors:  Sotirios Nedios; Jedrzej Kosiuk; Emmanuel Koutalas; Jelena Kornej; Philipp Sommer; Arash Arya; Sergio Richter; Sascha Rolf; Daniela Husser; Gerhard Hindricks; Andreas Bollmann
Journal:  J Interv Card Electrophysiol       Date:  2015-05-09       Impact factor: 1.900

6.  Measurement of Left Atrial Pressure is a Good Predictor of Freedom From Atrial Fibrillation.

Authors:  Leonard Bergau; Dirk Vollmann; Lars Luthje; Jan Martin Sohns; Joachim Seegers; Christian Sohns; Markus Zabel
Journal:  Indian Pacing Electrophysiol J       Date:  2014-07-15

7.  Prolonged P-wave duration is associated with atrial fibrillation recurrence after successful pulmonary vein isolation for paroxysmal atrial fibrillation.

Authors:  Jane Caldwell; Sahil Koppikar; Walid Barake; Damian Redfearn; Kevin Michael; Christopher Simpson; Wilma Hopman; Adrian Baranchuk
Journal:  J Interv Card Electrophysiol       Date:  2013-12-04       Impact factor: 1.900

8.  The Convergent Procedure - A Standardised and Anatomic Approach Addresses the Clinical and Economic Unmet Needs of the Persistent Atrial Fibrillation Population.

Authors:  James McKinnie
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11

9.  Topographic variability of the left atrium and pulmonary veins assessed by 3D-CT predicts the recurrence of atrial fibrillation after catheter ablation.

Authors:  Kunihiko Kiuchi; Akihiro Yoshida; Asumi Takei; Koji Fukuzawa; Mitsuaki Itoh; Kimitake Imamura; Ryudo Fujiwara; Atsushi Suzuki; Tomoyuki Nakanishi; Soichiro Yamashita; Ken-Ichi Hirata; Gaku Kanda; Katsunori Okajima; Akira Shimane; Shinichiro Yamada; Yasuyo Taniguchi; Yoshinori Yasaka; Hiroya Kawai
Journal:  J Arrhythm       Date:  2015-04-25

10.  The Association of Cardio-Ankle Vascular Index (CAVI) with Biatrial Remodeling in Atrial Fibrillation.

Authors:  Keijiro Nakamura; Takahito Takagi; Norihiro Kogame; Hikari Hashimoto; Masako Asami; Yasutake Toyoda; Yoshinari Enomoto; Hidehiko Hara; Mahito Noro; Kaoru Sugi; Masao Moroi; Masato Nakamura
Journal:  J Atheroscler Thromb       Date:  2020-08-29       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.